28 July 2011
Boston Scientific has continued to grow during its second fiscal quarter, helping to allay concerns sparked by CEO Ray Elliott's planned departure. He announced in May that he intends to retire at the end of the year, fuelling fears that the ...
28 July 2011
Diagnostics firm Alere has cut its full-year financial guidance to $2.50-2.60 per diluted share, after being hit by lower-than-expected revenues from its health management business. Sales in the unit were down to $135.6m in the second quarter, ...
22 July 2011
Devices were a weak spot in Abbott's second fiscal quarter results. Although sales of its Innovation-Driven Devices (comprising its vascular, ophthalmic and molecular diagnostics businesses) increased 3% to $1.2bn, this was due to a 5% favourable ...
01 March 2011
Chinese medtech company Mindray Medical International has had another year of growth, aided by a significant revenue increase from its international operations. Mindray recorded total revenues of $211m in the fourth quarter of 2010, up 12% over the ...
23 February 2011
Medtronic will increase its efforts to offload its underperforming Physio-Control defibrillator business as part of a bid to boost future financial growth.
The firm revealed its plans yesterday during a conference call to discuss its third ...
